Insights

Strong Funding Support ARMI has secured substantial federal funding totaling over $44 million, indicating robust governmental support and potential for innovative projects in regenerative medicine, which opens opportunities for companies offering compatible technologies, materials, and regulatory consulting.

Strategic Industry Collaborations ARMI partners with diverse organizations including universities, biotech firms, and manufacturing entities, creating opportunities to collaborate on R&D, supply chain solutions, and technology integration for tissue manufacturing and regenerative products.

Focused on Manufacturing Innovation The institute emphasizes scalable, GMP-compliant manufacturing processes, presenting a market for companies providing bioprocessing equipment, automation solutions, quality assurance tools, and regulatory support tailored to tissue engineering and regenerative production.

Market Expansion Potential With initiatives to commercialize engineered tissues and organ manufacturing, there is significant potential to engage with companies developing bioreactors, biofabrication platforms, and tissue scaffolds to meet emerging industry demands.

Growing Industry Ecosystem ARMI’s collaborations with research institutions, industry partners, and workforce development programs signal opportunities for technology vendors, training providers, and consulting firms to support the development of the regenerative medicine sector.

Similar companies to Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA

Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA Tech Stack

Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA uses 8 technology products and services including QuickBooks, WordPress, Webpack, and more. Explore Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA's tech stack below.

  • QuickBooks
    Accounting And Finance
  • WordPress
    Content Management System
  • Webpack
    Development
  • Shopify
    E-commerce
  • Microsoft 365
    Email
  • Vimeo
    Video Players
  • Adobe Fonts
    Web Fonts
  • Nginx
    Web Servers

Media & News

Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA's Email Address Formats

Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA uses at least 1 format(s):
Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA Email FormatsExamplePercentage
FLast@armiusa.orgJDoe@armiusa.org
49%
Last@armiusa.orgDoe@armiusa.org
1%
FLast@armiusa.orgJDoe@armiusa.org
49%
Last@armiusa.orgDoe@armiusa.org
1%

Frequently Asked Questions

Where is Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA's headquarters located?

Minus sign iconPlus sign icon
Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA's main headquarters is located at 400 Commercial Street Manchester, New Hampshire 03101 United States. The company has employees across 1 continents, including North America.

What is Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA's official website and social media links?

Minus sign iconPlus sign icon
Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA's official website is armiusa.org and has social profiles on LinkedInCrunchbase.

What is Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA's SIC code NAICS code?

Minus sign iconPlus sign icon
Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA have currently?

Minus sign iconPlus sign icon
As of March 2026, Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA has approximately 106 employees across 1 continents, including North America. Key team members include Chief Innovation Officer: J. L.Chief Regulatory Officer: R. M.Chief Operating Officer: J. M.. Explore Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA's employee directory with LeadIQ.

What industry does Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA belong to?

Minus sign iconPlus sign icon
Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA operates in the Biotechnology Research industry.

What technology does Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA use?

Minus sign iconPlus sign icon
Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA's tech stack includes QuickBooksWordPressWebpackShopifyMicrosoft 365VimeoAdobe FontsNginx.

What is Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA's email format?

Minus sign iconPlus sign icon
Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA's email format typically follows the pattern of FLast@armiusa.org. Find more Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA email formats with LeadIQ.

How much funding has Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA raised to date?

Minus sign iconPlus sign icon
As of March 2026, Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA has raised $44M in funding. The last funding round occurred on Jul 02, 2024 for $44M.

When was Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA founded?

Minus sign iconPlus sign icon
Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA was founded in 2016.

Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA

Biotechnology ResearchNew Hampshire, United States51-200 Employees

The BioFabUSA program is a public-private partnership between the Department of Defense (DoD) and the Advanced Regenerative Manufacturing Institute (ARMI), a member-driven, nonprofit organization whose mission is to make practical the scalable, consistent and cost-effective manufacturing of engineered tissues and tissue-related technologies, to benefit existing industries and grow new ones.

Within the last decade, significant breakthroughs in cell biology, biofabrication and materials science have laid the foundation for the large-scale manufacturing and commercialization of engineered tissues. However, the field of tissue engineering remains fragmented and lacks a mechanistic framework through which to translate laboratory discovery into manufactured products.

The goal of the institute is to close the gap in focus that inhibits the commercialization and translation of research and development. By removing existing regulatory hurdles, producing scalable, GMP-compliant processes, and establishing a commercial ecosystem, ARMI will help catalyze and foster the development of a new industry.

Section iconCompany Overview

Headquarters
400 Commercial Street Manchester, New Hampshire 03101 United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconFunding & Financials

  • $44M

    Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA has raised a total of $44M of funding over 1 rounds. Their latest funding round was raised on Jul 02, 2024 in the amount of $44M.

  • $50M$100M

    Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $44M

    Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA has raised a total of $44M of funding over 1 rounds. Their latest funding round was raised on Jul 02, 2024 in the amount of $44M.

  • $50M$100M

    Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.